Skip to content

Role of Individualized Homoeopathic Medicines in Cases of Dermatophytosis

Role of Individualized homoeopathic medicines in the management of Dermatophytosis assessed by Total symptoms score - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079764
Enrollment
100
Registered
2025-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINES: POTENCY VARIOUS DOSE AS PER NEED OF CASE FREQUANCY AS PER NEED OF CASE ROUTE OF ADMINISTRATION ORAL DURATION OF TREATMENT 8 MONTHS AS PER NEED O

Sponsors

DR YAMINIBEN PRAVINBHAI PATEL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group Participant aged 20 TO 60 years Gender Male and female Patient will be selected on the basis of ICD 11 code of dermatophytosis 1F28 Patient who gave voluntary consent to be include in the study

Exclusion criteria

Exclusion criteria: Cases of ringworm complicated with other skin complaint like Psoriasis Eczema Candidial infection Atopic dermatitis Cases of ringworm in immuno compromised patient like AIDS HIV and who are taking immunosuppressive therapy or corticosteroid Cases with other systemic illness like uncontrolled Diabetes mellitus Patient who are taking any other medication such as oinments external application Allopathic Homoeopathic Ayurvedic etc for dermatophytosis

Design outcomes

Primary

MeasureTime frame
TOTAL SYMPTOMS SCORE TO ASSESS REDUCTION IN DERMATOPHYTOSIS SYMPTOMSTimepoint: TOTAL SYMPTOMS SCORE WILL BE ASSESSED AT THE BASELINE AND AT THE END OF TREATMENT UPTO 8 MONTHS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR YAMINIBEN PRAVINBHAI PATEL

SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE

khamarvidhi5@gmail.com8866130328

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026